跳至主要内容
临床试验/JPRN-jRCT1031220344
JPRN-jRCT1031220344招募中4 期

Randomized, open-label, controlled study to evaluate the efficacy of angiotensin receptor neprilysin inhibitor in patients with aortic stenosis undergoing transcatheter aortic valve implantation.

Kitahara Hideki0 个研究点目标入组 84 人开始时间: 2022年9月22日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 70age old 至 ot applicable(—)
性别
All

入选标准

  • 1) A patient with aortic stenosis and the symptoms of heart failure requiring transcatheter aortic valve implantation based on 2020 Guideline on the Management of Valvular Heart Disease.
  • 2) A patient who is scheduled transcatheter aortic valve implantation at Chiba university hospital.
  • 3) A patient aged 70 years or older at the time of enrollment.
  • 4) A patient who has provided written informed consent to participate in this study (if the patient can not sign by oneself, it is acceptable that a family or a person following a family writes on behalf).

排除标准

  • 1) Acute heart failure (NYHA class IV)
  • 2) Systolic blood pressure <110 mmHg
  • 3) Severe hepatic dysfunction (Child-Pugh class C)
  • 4) Severe renal dysfunction (serum creatinine > 3.0mg/dL)
  • 5) Hemodialysis
  • 6) Hyperkalemia (serum K >5.5 mEq/L)
  • 7) Bilateral renal artery stenosis
  • 8) A history of angioedema
  • 9) A patient with diabetes on Aliskiren fumarate
  • 10) A patient without written informed consent
  • 11) A patient whom the investigator considers to be ineligible as a subject

研究者

发起方
Kitahara Hideki

相似试验